| A Phase I Safety and Immunogenicity Trial of the Facilitated HIV-1 Gag-Pol DNA Vaccine (APL-400-047, Apollon, Inc.) Given Intramuscularly by Needle and Syringe or Biojector 2000 Needle-Free Jet Injection System in HIV-1 Uninfected Adult Volunteers (NCT00001088) | National Institute of Allergy and Infectious Diseases (NIAID) | 1997-07-01 |
| Shortened Zidovudine Regimens to Prevent Mother-to-Child Transmission of HIV Type 1 (NCT00386230) | Institut de Recherche pour le Developpement | 1997-06-01 |
| A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Early Asymptomatic HIV Infection (NCT00002176) | Bristol-Myers Squibb | 1997-05-01 |
| A Pilot Open Label Trial of HIV Therapy With d4T (Stavudine), ddI (Didanosine), Nelfinavir and Hydroxyurea in Subjects With Recent HIV Infection (NCT00002177) | Bristol-Myers Squibb | 1997-05-01 |
| Studies of Ocular Complications of AIDS (SOCA)--Ganciclovir-Cidofovir CMV Retinitis Trial (GCCRT) (NCT00000143) | Johns Hopkins Bloomberg School of Public Health | 1997-05-01 |
| Phase II Randomized Study of Physiologic Testosterone Replacement in Premenopausal, HIV-Positive Women (NCT00004400) | Charles Drew University of Medicine and Science | 1997-04-01 |
| A Pilot Study of Non-Hodgkin's Lymphoma: Chemotherapy and Blood Levels of Organochlorines (NCT00001571) | National Cancer Institute (NCI) | 1997-02-01 |
| A Comparison of Valganciclovir and Ganciclovir in the Treatment of Cytomegalovirus (CMV) of the Eyes (NCT00002377) | Hoffmann-La Roche | 1997-01-01 |
| Clinical, Laboratory and Epidemiologic Pilot Studies of Individuals at High Risk for Viral-Associated Cancers (NCT00001560) | National Cancer Institute (NCI) | 1996-12-24 |
| A Study to Evaluate the Use of Memantine In Combination With Anti-HIV Drugs to Treat AIDS Dementia Complex (ADC) (NCT00000867) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-12-01 |
| The Safety and Effectiveness of Adefovir Dipivoxil in the Treatment of HIV-Infected Patients (NCT00001082) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-12-01 |
| Community Intervention Trial for Youth (CITY) Study (NCT00164580) | Centers for Disease Control and Prevention | 1996-10-01 |
| The Healthy Life Choices Project in HIV-Positive Patients (NCT00017810) | Columbia University | 1996-09-01 |
| HIV Symptom Management Program for African American Mothers (NCT00065819) | Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) | 1996-09-01 |
| The Effects of Prednisone on HIV Levels and the Immune System (NCT00000921) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-08-01 |
| A Comparison of Two Caloric Supplements in the Prevention of Weight Loss in Patients With AIDS Who Take Daily Multivitamin and Mineral Supplements (NCT00001077) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-06-01 |
| The Safety and Effectiveness of Lamivudine Plus Stavudine or Zidovudine in HIV-Infected Patients Who Have Taken Zidovudine (NCT00002371) | Bristol-Myers Squibb | 1996-06-01 |
| The Use of Bacteriophage Phi X174 to Assess the Immune Competence of HIV-Infected Patients In Vivo (NCT00001540) | National Institute of Allergy and Infectious Diseases (NIAID) | 1996-04-01 |
| Resistance to HIV Infection (NCT00069485) | National Institute of Allergy and Infectious Diseases (NIAID) | 1995-12-01 |
| Assessment of Attentional Functioning in Children With HIV-1 Infection (NCT00001497) | National Cancer Institute (NCI) | 1995-12-01 |
| A Study of Nitazoxanide in the Treatment of AIDS-Related Diarrhea (NCT00002444) | Unimed Pharmaceuticals | 1995-10-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--Monoclonal Antibody CMV Retinitis Trial (MACRT) (NCT00000135) | Johns Hopkins Bloomberg School of Public Health | 1995-09-01 |
| The Effect of Oral Candidiasis on the Speech Production, Feeding Skills, and Self-Concept of Children and Adolescents With Symptomatic HIV Infection (NCT00001448) | National Cancer Institute (NCI) | 1995-08-01 |
| A Phase I /II Study of the Protease Inhibitor Indinavir (MK-0639) in Children With HIV Infection (NCT00001443) | National Cancer Institute (NCI) | 1995-07-01 |
| A Pilot Study of the Combination of Retinoic Acid and Interferon-Alpha2a for the Treatment of Lymphoproliferative Disorders in Children With Immunodeficiency Syndromes (NCT00001438) | National Cancer Institute (NCI) | 1995-06-01 |
| Randomized Placebo-Controlled Study of Aerobic Exercise and Resistance Training Plus Megestrol Acetate for HIV-Wasting (NCT00004664) | National Center for Research Resources (NCRR) | 1995-06-01 |
| Psychosocial Correlates and Coping Strategies Associated With Long-Term Survival of HIV-Infected Children (NCT00001435) | National Cancer Institute (NCI) | 1995-04-01 |
| Trial of Vitamins in HIV Progression and Transmission (NCT00197743) | Harvard School of Public Health (HSPH) | 1995-04-01 |
| A Pilot Study to Compare the Antiviral and Immunologic Effects of Stavudine ( d4T ) Versus Placebo in Subjects With Evidence of Recent HIV Infection. (NCT00002349) | Bristol-Myers Squibb | 1995-01-01 |
| The Efficacy of a Standardized Acupuncture Regimen and Amitriptyline Compared With Placebo as a Treatment for Pain Caused by Peripheral Neuropathy in HIV-Infected Patients (NCT00000817) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-11-01 |
| Evaluation and Natural History of Children With Cancer and AIDS (NCT00001424) | National Cancer Institute (NCI) | 1994-11-01 |
| Viral Activation Transfusion Study (VATS) (NCT00000593) | National Heart, Lung, and Blood Institute (NHLBI) | 1994-11-01 |
| Women's Interagency HIV Study (WIHS) (NCT00000797) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-10-01 |
| A Study of Psychosocial and Behavioral Determinants of Differential Rates of Participant Compliance in CPCRA Protocols (NCT00000784) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-10-01 |
| Tuberculosis in a Multiethnic Inner City Population (NCT00005379) | NYU Langone Health | 1994-08-01 |
| A Phase I Trial to Evaluate the Safety and Pharmacokinetics of 1592U89 (NCT00002141) | Burroughs Wellcome | 1994-07-01 |
| Heterosexual HIV Transmission Study (HATS) (NCT00000783) | National Institute of Allergy and Infectious Diseases (NIAID) | 1994-06-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--HPMPC Peripheral CMV Retinitis Trial (HPCRT) (NCT00000142) | Johns Hopkins Bloomberg School of Public Health | 1994-04-01 |
| The Safety and Effectiveness of Clarithromycin Plus Ethambutol Used With or Without Clofazimine in the Treatment of MAC in Patients With AIDS (NCT00002331) | Abbott | 1994-01-01 |
| Evaluation of Three Regimens of Chemoprophylaxis for Tuberculosis in Patients co-Infected by HIV and Mycobacterium Tuberculosis (NCT00402454) | Sociedad Andaluza de Enfermedades Infecciosas | 1994-01-01 |
| A Randomized Trial of Three Regimens to Prevent Tuberculosis in HIV-Infected Patients With Anergy (NCT00402610) | Sociedad Andaluza de Enfermedades Infecciosas | 1994-01-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--Cytomegalovirus Retinitis Retreatment Trial (CRRT) (NCT00000134) | Johns Hopkins Bloomberg School of Public Health | 1992-12-01 |
| The Safety and Effectiveness of Clarithromycin in the Prevention of Mycobacterium Avium Complex (MAC) Infection in HIV-Infected Patients (NCT00002336) | Abbott | 1992-11-01 |
| Ganciclovir Implant Study for Cytomegalovirus Retinitis (NCT00000118) | National Eye Institute (NEI) | 1992-10-01 |
| A Registry of Tuberculosis Cases in the CPCRA (NCT00000785) | National Institute of Allergy and Infectious Diseases (NIAID) | 1992-08-01 |
| HIV Diversity and Pathogenesis in Donor-Recipient Clusters (NCT00005360) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-08-01 |
| Cardiac Autonomic Control in Children of HIV Positive Mothers (NCT00005353) | National Heart, Lung, and Blood Institute (NHLBI) | 1992-06-01 |
| Anti-HIV Immunoglobulin (HIVIG) in Prevention of Maternal-Fetal HIV Transmission (Pediatric ACTG Protocol 185) (NCT00000590) | National Heart, Lung, and Blood Institute (NHLBI) | 1991-09-01 |
| Phase II Placebo Controlled Study of Thalidomide in Patients With Mycobacterial and HIV Infections (NCT00004276) | National Center for Research Resources (NCRR) | 1990-09-01 |
| Prospective Study of HIV Infection in Hemophiliacs (NCT00005309) | Bloodworks | 1990-07-01 |
| Studies of the Ocular Complications of AIDS (SOCA)--Foscarnet-Ganciclovir CMV Retinitis Trial (FGCRT) (NCT00000136) | Johns Hopkins Bloomberg School of Public Health | 1990-03-01 |
| Phase II Study of the Efficacy of Peptide T in HIV-Positive Individuals With Cognitive Impairment. (NCT00000392) | National Institute of Mental Health (NIMH) | 1990-01-01 |
| Oral Manifestations of Human Immunodeficiency Virus Infection in High Risk Groups (NCT00004781) | National Institute of Dental and Craniofacial Research (NIDCR) | 1989-09-01 |
| Retrovirus Epidemiology Donor Study I (REDS I) (NCT00005278) | National Heart, Lung, and Blood Institute (NHLBI) | 1989-07-01 |
| Pediatric Pulmonary and Cardiovascular Complications of Vertically Transmitted HIV Infection (P2C2) (NCT00005274) | National Heart, Lung, and Blood Institute (NHLBI) | 1989-05-01 |
| Antiretroviral Pregnancy Registry (APR): Multi-sponsor Registry to Detect Any Major Teratogenic Effect Involving Any of the Registry Drugs When Administered to Pregnant People. (NCT00404989) | Syneos Health | 1989-01-01 |
| Erythropoietin for Anemia Due to Zidovudine in Human Immunodeficiency Virus Infection (NCT00000587) | Thomas Jefferson University | 1988-09-01 |
| AIDS-Associated Cardiomyopathy (NCT00005227) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-07-01 |
| HIV-Associated Heart Disease (NCT00005229) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-07-01 |
| AIDS-Associated Heart Disease -- Incidence and Etiology (NCT00005228) | National Heart, Lung, and Blood Institute (NHLBI) | 1988-07-01 |
| A Phase I Trial of Peptide T: Efficacy for the Neuropsychiatric Complications of Acquired Immunodeficiency Syndrome (AIDS). (NCT00000393) | National Institute of Mental Health (NIMH) | 1988-01-01 |
| A Phase I Trial of Intranasal Peptide T: Safety, Toxicity, and Pharmacokinetics in Human Immunodeficiency Virus-1 (HIV-1) Infected Patients. (NCT00000391) | National Institute of Mental Health (NIMH) | 1988-01-01 |
| Pulmonary Complications of HIV Infection Study (PACS) (NCT00005273) | National Heart, Lung, and Blood Institute (NHLBI) | 1987-09-01 |
| Prediction and Testing of Antigenic Sites of the AIDS Virus, HTLV-III Recognized by T Lymphocytes for the Development of Synthetic Vaccines (NCT00001210) | National Cancer Institute (NCI) | 1986-11-01 |
| Effectiveness of AIDS Antibody Screening (NCT00005303) | National Heart, Lung, and Blood Institute (NHLBI) | 1986-09-01 |
| Transfusion Safety Study (TSS) (NCT00005301) | National Heart, Lung, and Blood Institute (NHLBI) | 1984-09-01 |
| Multicenter AIDS Cohort Study (MACS) (NCT00046280) | National Institute of Allergy and Infectious Diseases (NIAID) | 1984-04-01 |
| Safety and Efficacy of Polyethylene Glycolated IL-2 (PEG IL-2) Plus Zidovudine or Dideoxyinosine in HIV Positive, Asymptomatic and Symptomatic Individuals (NCT00001997) | Chiron Corporation | |
| A Comparison of the Safety and Effectiveness of Fluconazole or Clotrimazole in the Treatment of Fungal Infections of the Mouth and Throat in Patients With AIDS (NCT00002282) | Pfizer | |
| An Open, Multicenter Study of Foscarnet Treatment of Acyclovir-Resistant Herpes Simplex Virus in Patients With the Acquired Immunodeficiency Syndrome and Other Immunodeficiencies (NCT00002272) | Astra USA | |
| Nystatin Pastilles for the Prevention of Oral Candidiasis in Patients With AIDS or ARC (NCT00002057) | Bristol-Myers Squibb | |
| Rosiglitazone in the Treatment of HIV-Associated Hyperlipidemia (NCT00006493) | National Center for Research Resources (NCRR) | |
| An Open Label Phase I Study of Subcutaneously Administered Recombinant Human GM-CSF in Patients With AIDS Virus Infection and Leukopenia (NCT00002008) | Sandoz | |
| Comparison of Fluconazole and Amphotericin B in the Treatment of Brain Infections in Patients With AIDS (NCT00001017) | Pfizer | |
| Safety and Effectiveness of the Vaccine ALVAC-HIV vCP205 in HIV-Negative Adult Volunteers in Uganda (NCT00007423) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety of Different Dose Levels of Zidovudine in HIV-Infected Children (NCT00000983) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving Indinavir, Ritonavir, Stavudine, and Lamivudine to HIV-Infected Patients Who Have Never Received Anti-HIV Drugs (NCT00002451) | Merck Sharp & Dohme LLC | |
| A Phase I Open-Label Study of the Safety, Tolerance, and Pharmacokinetic Interactions of Combination Didanosine and Ribavirin in HIV-Positive Individuals (NCT00000772) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study to Learn More About MAC Disease and the Use of Anti-HIV Drugs in Patients With Advanced HIV Infection (NCT00000895) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Multicenter Comparison of Fluconazole (UK-49,858) and Amphotericin B as Treatment for Acute Cryptococcal Meningitis (NCT00002075) | Pfizer | |
| A Phase I, Placebo-Controlled, Dose-Escalation Study of the Safety, Tolerability, and Pharmacokinetics of Thalidomide in Subjects With HIV-1 Infection (NCT00000812) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Comparison of Zidovudine (AZT) and Stavudine in HIV-Infected Patients (NCT00002307) | Bristol-Myers Squibb | |
| Primary Prophylaxis of Cerebral Toxoplasmosis in HIV-Infected Patients (NCT00000643) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Study of Efavirenz in Combination With Stavudine and Didanosine (NCT00002225) | Dupont Merck | |
| Depot Disulfiram for AIDS and ARC (NCT00002065) | St. Vincent's Medical Center | |
| A Multicenter Study To Determine Foscarnet Dose Response in HIV Infected Patients With PGL and/or Constitutional Disease (NCT00000729) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Double-Blind, Randomized Parallel Group Study Comparing Procysteine to Placebo in HIV-Infected Patients Who Are Taking Antiretroviral Nucleosides (NCT00002114) | Free Radical Sciences | |
| A Study of the Effectiveness of Different Anti-HIV Treatments in HIV-Positive Individuals Who Have Been on a Protease Inhibitor-Containing Drug Regimen for at Least 16 Weeks (NCT00000914) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Use of a Varicella-Zoster Virus (VZV) Vaccine to Prevent Shingles in HIV-Infected Children Who Have Already Had Chickenpox (NCT00001125) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Dose-Frequency Trial of Oral Retrovir in Patients With AIDS or Severe ARC (NCT00002046) | Glaxo Wellcome | |
| A Multiple Dose Crossover Pharmacokinetics Study to Evaluate the Effects of Food on the Absorption of Oral Ganciclovir (NCT00002251) | Hoffmann-La Roche | |
| A Phase III Randomized Trial of Low-Dose Versus Standard-Dose mBACOD Chemotherapy With rGM-CSF for Treatment of AIDS-Associated Non-Hodgkin's Lymphoma (NCT00000658) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Phase I Pharmacokinetic and Tolerance Study of Ribavirin in Human Immunodeficiency Virus (HIV) - Infected Patients (NCT00000733) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| The Safety and Effectiveness of Lamivudine Plus Zidovudine, Used With and Without 1592U89, in HIV-1 Infected Patients Who Have Never Taken Anti-HIV Drugs (NCT00002389) | Glaxo Wellcome | |
| A Study of DPC 817 in HIV-Infected Males (NCT00040274) | Pharmasset | |
| Further Evaluation of Thalidomide's Ability to Potentiate the Immune Response to HIV-Infected Patients (NCT00002174) | Louisiana State University Health Sciences Center in New Orleans | |
| The Safety and Effectiveness of Zidovudine (AZT) in the Treatment of HIV Infection in Patients With AIDS and Advanced ARC (NCT00000999) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| A Phase I/II Study of Intralesional Recombinant Tumor Necrosis Factor in Patients With AIDS-Related Cutaneous Kaposi's Sarcoma (NCT00002262) | University of California, San Francisco | |
| Effects of Ribavirin on Zidovudine or Stavudine (NCT00021632) | National Institute of Allergy and Infectious Diseases (NIAID) | |
| Safety and Effectiveness of Giving L-743,872 to Patients With Thrush That Has Not Been Cured With Fluconazole (NCT00005920) | Merck Sharp & Dohme LLC | |